A 7-Year Single-Centre Outcomes for Esophageal Stenting: Retrospective Analysis of 454 Procedures

Background: This study aimed to assess the factors contributing to the technical and clinical success of esophageal stenting

Materials and Methods: Retrospective single-center study of all patients who underwent esophageal stenting from 2011 to 2018 was collected. Information for analysis was gathered with the use of RIS/PACS, histopathology records, patient clinical notes, and ICE. Pathology subtype, location of lesion, and types of stents used were also collected. Complications and rates of reintervention within 30 days (immediate) and up to a year (long term) within the procedure were evaluated. Average survival rates from insertion, as well as 30-day, and overall 1-year survival were analyzed.

Results: Among 392 patients with esophageal malignancy, less than 1% had immediate- or long-term complications. Among 31 patients with other cancers, no immediate or late complication was recorded. Among 23 patients with benign strictures, 9% reported immediate- and long-term complications. Among five patients with postoperative esophageal leakage, three reported immediate complications and one long-term complication. No procedure-related deaths recorded within our patient cohort. Average time to death after palliative esophageal stenting was 5 months for patients with esophageal cancer and 2 months for other cancers. The technical success of esophageal stenting was 100%, with only 2% of patients requiring reintervention at 30 days and less than 1% at 1 year.

Conclusion: Esophageal stenting is a safe procedure for the palliation of dysphagia caused by advanced esophageal cancer or malignant extrinsic compression of the esophagus. In our experience, there is minimal postprocedural complication and mortality, which is comparable with published studies.

Publikationsverlauf

Artikel online veröffentlicht:
14. Dezember 2021